MEN2312
/ Menarini, Insilico Medicine
- LARVOL DELTA
Home
Next
Prev
1 to 3
Of
3
Go to page
1
October 01, 2025
A First-in-Human Study of MEN2312 in Adults With Advanced Breast Cancer
(clinicaltrials.gov)
- P1 | N=240 | Recruiting | Sponsor: Stemline Therapeutics, Inc. | N=124 ➔ 240
Enrollment change • First-in-human • Monotherapy • Breast Cancer • Oncology • Solid Tumor
October 30, 2024
A First-in-Human Study of MEN2312 in Adults With Advanced Breast Cancer
(clinicaltrials.gov)
- P1 | N=124 | Recruiting | Sponsor: Stemline Therapeutics, Inc. | Not yet recruiting ➔ Recruiting
Enrollment open • Metastases • Monotherapy • Breast Cancer • Oncology • Solid Tumor
October 15, 2024
A First-in-Human Study of MEN2312 in Adults With Advanced Breast Cancer
(clinicaltrials.gov)
- P1 | N=124 | Not yet recruiting | Sponsor: Stemline Therapeutics, Inc.
Metastases • Monotherapy • New P1 trial • Breast Cancer • Oncology • Solid Tumor
1 to 3
Of
3
Go to page
1